Gender based Differences in COVID-19 patients: Gender based Differences in COVID-19 patients

Sami Ullah  Mumtaz; Somia  Iqtadar; Sajid  Abaidullah; Khalid Masood  Gondal; Amber  Hassan; Asad Aslam  Khan; Javed  Akram

doi:10.52229/pbmj.v3i2.14

Authors

Sami Ullah Mumtaz Department of Medicine, King Edward Medical University/Mayo Hospital Lahore, Pakistan
Somia Iqtadar Department of Medicine, King Edward Medical University/Mayo Hospital Lahore, Pakistan
Sajid Abaidullah Department of Medicine, King Edward Medical University/Mayo Hospital Lahore, Pakistan
Khalid Masood Gondal Department of Surgery,King Edward Medical University/Mayo Hospital, Lahore, Pakistan
Amber Hassan Faculty of Allied Health Sciences, The University of Lahore, Pakistan
Asad Aslam Khan Department of Ophthalmology,King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Javed Akram Institute for Regenerative Medicine, University of Health Sciences, Lahore, Pakistan

DOI:

https://doi.org/10.52229/pbmj.v3i2.14

Abstract

Coronaviruses are a huge family of viruses that originate disease extending from the common cold to further fatal maladies.Objective:The study was conducted to determine the gender based differences in COVID-19 patients.Methods:Study included total 150 participants visiting Department of Medicine, Mayo Hospital, Lahore, Pakistan.Data were collected through self-structured questionnaire using non-probability convenient sampling. Prior written informed consents were taken from the participants. Ethical approval was taken fromThe University of Lahore, Lahore. Data were analyzed through SPSS version 25.0.Results:Results showed that among the comorbidities hypertension was most common in COVID-19 patients followed by diabetes mellitus, especially in females. Whereas renal disorders and asthma were most reported in males.Analysis revealed that there was a significant association (p=0.001) between disease severity and gender.Conclusion:Study concluded that there was significant association between gender and disease severity.

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, (2020).Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet.395(10224):565-74.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T, (2020).Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet.395(10223):507-13.

Deng SQ, Peng HJ, (2020).Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of clinical medicine, 9(2):575.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, (2020).Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet,395(10223):497-506.

Wang B, Li R, Lu Z, Huang Y, (2020).Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.Aging (Albany NY).12(7):6049.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y, (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology.109(5):531-8.

Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, Nguyen TT, Cao TM, Pham QD, (2020). Importation and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine. 382(9):872-4.

Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England journal of medicine.382(10):970-1.

Wu Z, McGoogan JM, (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 323(13):1239-42.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M, (2020). Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama. 323(16):1612-4.

Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, Tang C, Sang L, Liu J, Ni Z, Hu Y, (2020). Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 158(1):97-105.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 382(18):1708-20.

Young BE, Ong SW, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, (2020). Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. Jama. 323(15):1488-94.

Wan S, Xiang YI, Fang W, Zheng Y, Li B, Hu Y, Lang C, Huang D, Sun Q, Xiong Y, Huang X, (2020). Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology. 92(7):797-806.

Martínez A, Soldevila N, Romero-Tamarit A, Torner N, Godoy P, Rius C, Jané M, Domínguez À, Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working Group, (2019). Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype. PLoS One. 14(1):e0210353.

Mauskopf J, Klesse M, Lee S, Herrera-Taracena G, (2013). The burden of influenza complications in different high-risk groups: a targeted literature review. Journal of medical economics. 16(2):264-77.

Placzek HE, Madoff LC, (2014). Association of age and comorbidity on 2009 influenza A pandemic H1N1-related intensive care unit stay in Massachusetts. American journal of public health. 104(11):e118-25.

Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, (2003). Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.Jama. 289(21):2801-9.

Deng SQ, Peng HJ, (2020). Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of clinical medicine. 9(2):575.

Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X, (2020). Analysis of 92 deceased patients with COVID‐19. Journal of medical virology. 92(11):2511-5.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 395(10223):497-506.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 323(11):1061-9.

Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP, (2020). Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med.382: 2049-55.

Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, Wang Y, (2020). Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International Journal of Infectious Diseases. 99:47-56

Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 8(5):475-81.

Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q, (2020). Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. 159(1):367-70.